{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:40:50Z","timestamp":1787582450440,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Poor glycemic control is a significant public health issue, contributing to the development of complications, increasing healthcare costs, and quality of life. The objective of the meta-analysis is to estimate the prevalence of poor glycemic control and its prevalence according to diagnostic criteria in diabetic hypertensive patients. Findings will be critical in reducing the burden of poor glycemic control and complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted in accordance with the PRISMA 2020 guidelines. Three electronic databases (PubMed, Web of Science, and SCOPUS) were searched for studies published in English between January 2015 and January 2025. Primary studies assessed glycemic control among diabetic-hypertensive patients using one or more of the following: a fasting blood glucose (FBG) level (&gt;\u2009126\u00a0mg\/dL, &gt;\u2009130\u00a0mg\/dL, or &gt;\u2009130\u00a0mg\/dL) and\/or glycated hemoglobin A1C level (\u2265\u20097%). Random-effects models (metaprop, REML) were used to estimate pooled prevalence. Heterogeneity, sensitivity test, subgroup analysis, and publication bias assessments were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, ten papers involving a total of 2552 individuals were utilized to derive the pooled estimate. The pooled prevalence of poor glycemic control was 59% (95%CI; 0.49\u20130.69). Based on diagnostic criteria the pooled prevalence of poor glycemic control in diabetic hypertensive patients was 46% (95%CI: 0.31\u20130.61), and 65% (95%CI; 0.54\u20130.76) for fasting blood glucose and glycosylated hemoglobin respectively. There is substantial heterogeneity but no significant publication bias on visual inspection of the forest plot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Around two-third of study participants have poor glycemic control in diabetic hypertensive patients. This finding is important as a baseline for refining clinical guidelines and improving long-term outcomes for this high-risk group. Future researchers will evaluate effective interventions to improve glycemic control in diabetic hypertensive patients across diverse study settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02357-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:25:13Z","timestamp":1781515513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of poor glycemic control in diabetic hypertensive patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Dula Dessalegn","family":"Bosho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas Deressa","family":"Guracho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selamawit Worku","family":"Asmare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behailu Terefe","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diriba Dereje","family":"Olana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesema Etefa","family":"Birhanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2357_CR1","unstructured":"World Health Organization Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases. World Health Organization; 2024."},{"issue":"1","key":"2357_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13104-018-3423-5","volume":"11","author":"T Fiseha","year":"2018","unstructured":"Fiseha T, Alemayehu E, Kassahun W, Adamu A, Gebreweld A. Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia. BMC Res Notes. 2018;11(1):316.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2357_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12872-023-03478-3","volume":"23","author":"S Chen","year":"2023","unstructured":"Chen S, Zhu Y, Jin S, Zhao D, Guo J, Chen L, et al. Association of glycemic control with hypertension in patients with diabetes: a population-based longitudinal study. BMC Cardiovasc Disord. 2023;23(1):501.","journal-title":"BMC Cardiovasc Disord"},{"key":"2357_CR4","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2357_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2357_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12872-023-03357-x","volume":"23","author":"F Farhadi","year":"2023","unstructured":"Farhadi F, Aliyari R, Ebrahimi H, Hashemi H, Emamian MH, Fotouhi A. Prevalence of uncontrolled hypertension and its associated factors in 50\u201374 years old Iranian adults: a population-based study. BMC Cardiovasc Disord. 2023;23(1):318.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2357_CR7","doi-asserted-by":"publisher","first-page":"18892","DOI":"10.1038\/s41598-024-69062-7","volume":"14","author":"A Taheri","year":"2024","unstructured":"Taheri A, Khezri R, Dehghan A, Rezaeian M, Aune D, Rezaei F. Hypertension among persons with type 2 diabetes and its related demographic, socioeconomic and lifestyle factors in the Fasa cohort study. Sci Rep. 2024;14(1):18892.","journal-title":"Sci Rep"},{"issue":"8","key":"2357_CR8","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347\u2013913.","journal-title":"Circulation"},{"issue":"5","key":"2357_CR9","first-page":"575","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575\u201384.","journal-title":"Can J Cardiol"},{"key":"2357_CR10","doi-asserted-by":"crossref","unstructured":"Zhang C, Chen R, Wang S, Du R, Li Q, Guo Y, et al. The first prospective registry-based cohort study focused on type 2 diabetes mellitus patients from high-altitude regions: the HLA-DR study protocol. 2023.","DOI":"10.21203\/rs.3.rs-3278775\/v1"},{"issue":"5","key":"2357_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.xkme.2021.04.018","volume":"3","author":"J Hong","year":"2021","unstructured":"Hong J, Surapaneni A, Daya N, Selvin E, Coresh J, Grams ME, et al. Retinopathy and risk of kidney disease in persons with diabetes. Kidney Med. 2021;3(5):808\u201315. e1.","journal-title":"Kidney Med"},{"issue":"1","key":"2357_CR12","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41598-019-44169-4","volume":"9","author":"X Cai","year":"2019","unstructured":"Cai X, Hu D, Pan C, Li G, Lu J, Ji Q, et al. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study. Sci Rep. 2019;9(1):7709.","journal-title":"Sci Rep"},{"key":"2357_CR13","doi-asserted-by":"crossref","unstructured":"Tewari A, Kumar G, Maheshwari A, Tewari V, Tewari J. Comparative evaluation of waist-to-height ratio and BMI in predicting adverse cardiovascular outcome in people with diabetes: a systematic review. Cureus. 2023;15(5).","DOI":"10.7759\/cureus.38801"},{"issue":"1","key":"2357_CR14","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1038\/s41598-023-36675-3","volume":"13","author":"JJ Yahaya","year":"2023","unstructured":"Yahaya JJ, Doya IF, Morgan ED, Ngaiza AI, Bintabara D. Poor glycemic control and associated factors among patients with type 2 diabetes mellitus: a cross-sectional study. Sci Rep. 2023;13(1):9673.","journal-title":"Sci Rep"},{"key":"2357_CR15","doi-asserted-by":"publisher","first-page":"004695802311557","DOI":"10.1177\/00469580231155716","volume":"60","author":"ZW Bitew","year":"2023","unstructured":"Bitew ZW, Alemu A, Jember DA, Tadesse E, Getaneh FB, Seid A, et al. Prevalence of glycemic control and factors associated with poor glycemic control: a systematic review and meta-analysis. INQUIRY: J Health Care Organ Provis Financing. 2023;60:00469580231155716.","journal-title":"INQUIRY: J Health Care Organ Provis Financing"},{"key":"2357_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.puhe.2023.10.015","volume":"225","author":"P Pitak","year":"2023","unstructured":"Pitak P, Tasai S, Kumpat N, Songkla PN, Fuangchan A, Krass I, et al. The prevalence of glycemic control in patients with type 2 diabetes treated with insulin: a systematic review and meta-analysis. Public Health. 2023;225:218\u201328.","journal-title":"Public Health"},{"key":"2357_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40\u201350.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2357_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12902-023-01515-y","volume":"23","author":"MF Dinavari","year":"2023","unstructured":"Dinavari MF, Sanaie S, Rasouli K, Faramarzi E, Molani-Gol R. Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population. BMC Endocr Disorders. 2023;23(1):273.","journal-title":"BMC Endocr Disorders"},{"key":"2357_CR19","doi-asserted-by":"crossref","unstructured":"Jarab AS, Al-Qerem W, Alqudah S, Abu Heshmeh S, Mukattash TL, Beiram R et al. Glycemic control and its associated factors in hypertensive patients with type 2 diabetes. Eur Rev Med Pharmacol Sci. 2023;27(12).","DOI":"10.29333\/ejgm\/13028"},{"issue":"02","key":"2357_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.55489\/njcm.170220266176","volume":"17","author":"B Gupta","year":"2026","unstructured":"Gupta B, Gupta S, Singh R, Verma N, Gupta K, Goel R, et al. Effectiveness of Digital Health Interventions on Glycemic Control in Adults with Type 2 Diabetes: A Systematic Review, Network Meta-Analysis, and RE-AIM Implementation Assessment. Natl J Community Med. 2026;17(02):77\u201392.","journal-title":"Natl J Community Med"},{"key":"2357_CR21","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"key":"2357_CR22","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"D Care","year":"2022","unstructured":"Care D. Care in diabetes\u20142022. Diabetes Care. 2022;45:S17.","journal-title":"Diabetes Care"},{"key":"2357_CR23","volume-title":"Meta analysis of statistics assessment and review instrument","author":"T Schultz","year":"2007","unstructured":"Schultz T, Florence Z. Meta analysis of statistics assessment and review instrument. Adelaide, South Australia: The Joanna Briggs Institute; 2007."},{"key":"2357_CR24","unstructured":"Ortiz G, editor. New meta-analysis (MA) features in Stata 18: MA for prevalence and multilevel MA. In: Can Stata Conf 2023; 2023: Stata Users Group."},{"issue":"3","key":"2357_CR25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","volume":"13","author":"CB Migliavaca","year":"2022","unstructured":"Migliavaca CB, Stein C, Colpani V, Barker TH, Ziegelmann PK, Munn Z, et al. Meta-analysis of prevalence: I 2 statistic and how to deal with heterogeneity. Res synthesis methods. 2022;13(3):363\u20137.","journal-title":"Res synthesis methods"},{"issue":"1","key":"2357_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40885-017-0085-x","volume":"23","author":"S Muleta","year":"2017","unstructured":"Muleta S, Melaku T, Chelkeba L, Assefa D. Blood pressure control and its determinants among diabetes mellitus co-morbid hypertensive patients at Jimma University medical center, South West Ethiopia. Clin Hypertens. 2017;23(1):29.","journal-title":"Clin Hypertens"},{"key":"2357_CR27","doi-asserted-by":"crossref","unstructured":"Yimam M, Desse TA, Hebo HJ. Glycemic control among ambulatory type 2 diabetes patients with hypertension co-morbidity in a developing country: a cross-sectional study. Heliyon. 2020;6(12).","DOI":"10.1016\/j.heliyon.2020.e05671"},{"issue":"1","key":"2357_CR28","doi-asserted-by":"publisher","first-page":"7526257","DOI":"10.1155\/2020\/7526257","volume":"2020","author":"MG Dedefo","year":"2020","unstructured":"Dedefo MG, Gemechu DB, Fekadu G, Tekle Dibessa T. Blood pressure control among hypertensive diabetic patients on follow-up at chronic Clinic of Nekemte Referral Hospital in West Ethiopia. Int J Hypertens. 2020;2020(1):7526257.","journal-title":"Int J Hypertens"},{"key":"2357_CR29","doi-asserted-by":"crossref","unstructured":"Akalu Y, Belsti Y. Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor General Hospital, northwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13:1621-1631.","DOI":"10.2147\/DMSO.S254537"},{"issue":"5","key":"2357_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4314\/ejhs.v27i5.5","volume":"27","author":"SB Kilonzo","year":"2017","unstructured":"Kilonzo SB, Gunda DW, Bakshi FA, Kalokola F, Mayala HA, Dadi H. Control of hypertension among diabetic patients in a referral hospital in Tanzania: a cross-sectional study. Ethiop J health Sci. 2017;27(5):473.","journal-title":"Ethiop J health Sci"},{"key":"2357_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.11604\/pamj.2021.39.142.28620","volume":"39","author":"PK Saasita","year":"2021","unstructured":"Saasita PK, Senoga S, Muhongya K, Agaba DC, Migisha R. High prevalence of uncontrolled hypertension among patients with type 2 diabetes mellitus: a hospital-based cross-sectional study in southwestern Uganda. Pan Afr Med J. 2021;39:142.","journal-title":"Pan Afr Med J"},{"issue":"12","key":"2357_CR32","doi-asserted-by":"publisher","first-page":"e0001342","DOI":"10.1371\/journal.pgph.0001342","volume":"2","author":"Y Alhassan","year":"2022","unstructured":"Alhassan Y, Kwakye AO, Dwomoh AK, Baah-Nyarkoh E, Ganu VJ, Appiah B, et al. Determinants of blood pressure and blood glucose control in patients with co-morbid hypertension and type 2 diabetes mellitus in Ghana: a hospital-based cross-sectional study. PLOS Global Public Health. 2022;2(12):e0001342.","journal-title":"PLOS Global Public Health"},{"issue":"4","key":"2357_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/aam.aam_78_21","volume":"21","author":"O Adegoke","year":"2022","unstructured":"Adegoke O, Bello BT, Olorunfemi G, Odeniyi IA. Prevalence of hypertension and determinants of poor blood pressure control in patients with type 2 diabetes mellitus attending a tertiary clinic in lagos, Nigeria. Ann Afr Med. 2022;21(4):348\u201354.","journal-title":"Ann Afr Med"},{"key":"2357_CR34","doi-asserted-by":"crossref","unstructured":"Burney S, Asad M, Fazal M, Zulfiqar A. Hypertension in Type 2 Diabetes and its association with glycemic control: a hospital-based study from Pakistan. Isra Med J. 2023;15(1).","DOI":"10.55282\/imj.oa1392."},{"key":"2357_CR35","doi-asserted-by":"publisher","first-page":"1256024","DOI":"10.3389\/fpubh.2024.1256024","volume":"12","author":"KD Tegegne","year":"2024","unstructured":"Tegegne KD, Gebeyehu NA, Yirdaw LT, Yitayew YA, Kassaw MW. Determinants of poor glycemic control among type 2 diabetes in Ethiopia: a systematic review and meta-analysis. Front Public Health. 2024;12:1256024.","journal-title":"Front Public Health"},{"issue":"8","key":"2357_CR36","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jan.15255","volume":"78","author":"OH Al-ma\u2019aitah","year":"2022","unstructured":"Al-ma\u2019aitah OH, Demant D, Jakimowicz S, Perry L. Glycaemic control and its associated factors in patients with type 2 diabetes in the Middle East and North Africa: An updated systematic review and meta\u2010analysis. J Adv Nurs. 2022;78(8):2257\u201376.","journal-title":"J Adv Nurs"},{"issue":"1","key":"2357_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13098-022-00902-0","volume":"14","author":"J-P Fina Lubaki","year":"2022","unstructured":"Fina Lubaki J-P, Omole OB, Francis JM. Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis. Diabetol Metab Syndr. 2022;14(1):134.","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"2357_CR38","doi-asserted-by":"publisher","first-page":"e0221790","DOI":"10.1371\/journal.pone.0221790","volume":"14","author":"EA Gebreyohannes","year":"2019","unstructured":"Gebreyohannes EA, Netere AK, Belachew SA. Glycemic control among diabetic patients in Ethiopia: a systematic review and meta-analysis. PLoS ONE. 2019;14(8):e0221790.","journal-title":"PLoS ONE"},{"issue":"1","key":"2357_CR39","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1038\/s41598-019-46766-9","volume":"9","author":"A Afroz","year":"2019","unstructured":"Afroz A, Ali L, Karim MN, Alramadan MJ, Alam K, Magliano DJ, et al. Glycaemic control for people with type 2 diabetes mellitus in Bangladesh-an urgent need for optimization of management plan. Sci Rep. 2019;9(1):10248.","journal-title":"Sci Rep"},{"key":"2357_CR40","doi-asserted-by":"crossref","unstructured":"Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf. 2014;6:155-165.","DOI":"10.2147\/DHPS.S68786"},{"issue":"9","key":"2357_CR41","doi-asserted-by":"publisher","first-page":"e0268177","DOI":"10.1371\/journal.pone.0268177","volume":"17","author":"J-P Fina Lubaki","year":"2022","unstructured":"Fina Lubaki J-P, Omole OB, Francis JM. Protocol: Developing a framework to improve glycaemic control among patients with type 2 diabetes mellitus in Kinshasa, Democratic Republic of the Congo. PLoS ONE. 2022;17(9):e0268177.","journal-title":"PLoS ONE"},{"issue":"5","key":"2357_CR42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/00015385.2017.1297626","volume":"72","author":"T Di Chiara","year":"2017","unstructured":"Di Chiara T, Scaglione A, Corrao S, Argano C, Pinto A, Scaglione R. Education and hypertension: impact on global cardiovascular risk. Acta Cardiol. 2017;72(5):507\u201313.","journal-title":"Acta Cardiol"},{"issue":"5","key":"2357_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/jch.12506","volume":"17","author":"T Di Chiara","year":"2015","unstructured":"Di Chiara T, Scaglione A, Corrao S, Argano C, Pinto A, Scaglione R. Association between low education and higher global cardiovascular risk. J Clin Hypertens. 2015;17(5):332\u20137.","journal-title":"J Clin Hypertens"},{"issue":"10","key":"2357_CR44","doi-asserted-by":"publisher","first-page":"18381","DOI":"10.3390\/ijms151018381","volume":"15","author":"Y Saisho","year":"2014","unstructured":"Saisho Y. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? Int J Mol Sci. 2014;15(10):18381\u2013406.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2357_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","volume":"10","author":"H Chehregosha","year":"2019","unstructured":"Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A view beyond HbA1c: role of continuous glucose monitoring. Diabetes Therapy. 2019;10(3):853\u201363.","journal-title":"Diabetes Therapy"},{"issue":"24","key":"2357_CR46","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.2174\/1381612824666180903121957","volume":"24","author":"K Prasad","year":"2018","unstructured":"Prasad K. Does HbA1cc play a role in the development of cardiovascular diseases? Curr Pharm Design. 2018;24(24):2876\u201382.","journal-title":"Curr Pharm Design"},{"issue":"8","key":"2357_CR47","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.3390\/ijerph18084292","volume":"18","author":"W-Y Yao","year":"2021","unstructured":"Yao W-Y, Han M-G, De Vito G, Fang H, Xia Q, Chen Y, et al. Physical activity and glycemic control status in chinese patients with type 2 diabetes: a secondary analysis of a randomized controlled trial. Int J Environ Res Public Health. 2021;18(8):4292.","journal-title":"Int J Environ Res Public Health"},{"key":"2357_CR48","doi-asserted-by":"publisher","first-page":"767152","DOI":"10.3389\/fendo.2021.767152","volume":"12","author":"X Zhu","year":"2021","unstructured":"Zhu X, Zhao L, Chen J, Lin C, Lv F, Hu S, et al. The effect of physical activity on glycemic variability in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2021;12:767152.","journal-title":"Front Endocrinol"},{"issue":"12","key":"2357_CR49","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.2337\/dc16-1145","volume":"39","author":"M de Groot","year":"2016","unstructured":"de Groot M, Crick KA, Long M, Saha C, Shubrook JH. Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care. 2016;39(12):2174\u201381.","journal-title":"Diabetes Care"},{"issue":"4","key":"2357_CR50","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00394-019-02147-6","volume":"59","author":"L Garcia-Molina","year":"2020","unstructured":"Garcia-Molina L, Lewis-Mikhael A-M, Riquelme-Gallego B, Cano-Ibanez N, Oliveras-Lopez M-J, Bueno-Cavanillas A. Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysis. Eur J Nutr. 2020;59(4):1313\u201328.","journal-title":"Eur J Nutr"},{"issue":"11","key":"2357_CR51","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2337\/dc16-1728","volume":"39","author":"SR Colberg","year":"2016","unstructured":"Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02357-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:03:25Z","timestamp":1787580205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02357-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2357"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02357-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"245"}}